Public/private sector partnership for emerging infections

Area of Science:

• Epidemiology
• Infectious Diseases
• Public Health Policy

Background:

• Emerging infectious diseases pose a significant global health threat.
• Current investment in this area is substantial but could be optimized.
• The role of diverse funding sources requires further examination.

Purpose of the Study:

• To explore the impact of public-private partnerships (PPPs) on emerging infectious diseases.
• To highlight the catalytic role of philanthropy in research and development.
• To suggest strategies for increasing investment in infectious disease control.

Main Methods:

• Review of existing public-private partnership models.
• Analysis of funding streams from government, industry, and philanthropy.
• Case study examples of successful partnerships.

Main Results:

• PPPs effectively support research, drug development, and policy advancement.
• Philanthropy, despite smaller investment, acts as a crucial catalyst for innovation.
• Government and industry are the largest investors in emerging infectious diseases.

Conclusions:

• Public-private partnerships are vital for enhancing understanding and control of emerging infections.
• Philanthropic investment can be strategically leveraged to attract greater funding.
• Defining and advocating for the value of philanthropic investment is key to future growth.